U.S. Pharmaceuticals & Biotech Most Popular Stocks

Q BioMed

Market Cap: US$145.0

A biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies.

CannTrust Holdings

Market Cap: US$141.0

Produces and distributes medical and recreational cannabis in Canada.

Eden Empire

Market Cap: US$137.0

Invests in and operates in the cannabis sector.

Seelos Therapeutics

Market Cap: US$136.0

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders.

PsyBio Therapeutics

Market Cap: US$132.0

A biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States.

Marizyme

Market Cap: US$131.0

A multi-technology life science company, engages in the research, manufacture, and commercialization of medical devices, diagnostics, and products to address clinical needs in the United States, Europe, and Asia.

Microart

Market Cap: US$130.0

Researches and develops innovative stem cell solutions and therapeutic applications of adult stem cells.

Lattice Biologics

Market Cap: US$128.0

A biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide.

Isodiol International

Market Cap: US$128.0

Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States.

Emerging World Pharma

Market Cap: US$119.0

Invests in generic based pharmaceutical companies manufacturing within developing nations.

HEALTHeUNIVERSE

Market Cap: US$117.0

Healtheuniverse, Inc., a biotechnology development company, engages in the research, development, and commercialization of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products.

RxElite

Market Cap: US$116.0

Engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets.

VMS Rehab Systems

Market Cap: US$111.0

Engages in generic drug and home healthcare businesses.

RVL Pharmaceuticals

Market Cap: US$111.0

Operates as a specialty pharmaceutical company.

RenovaCare

Market Cap: US$87.0

A development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications.

Alliance Growers

Market Cap: US$85.0

Engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia.

Gnomestar Craft

Market Cap: US$85.0

Engages in the production and distribution of cannabis product for medical and recreational use in Canada.

Cardax

Market Cap: US$82.0

A biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress.

Yield10 Bioscience

Market Cap: US$73.0

Operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.

Indigenous Bloom Hemp

Market Cap: US$71.0

Focuses on the production of hemp products.

Interpharm Holdings

Market Cap: US$66.0

Develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.

North Bud Farms

Market Cap: US$66.0

Through its subsidiaries, focuses on the production of pharmaceutical-grade cannabis and food grade cannabinoid infused inputs for the pharmaceutical and recreational cannabis markets in Canada.

Capha Pharmaceuticals

Market Cap: US$64.0

Does not have significant operations.

MJ Holdings

Market Cap: US$58.0

A cannabis holding company, engages in cultivation management, asset, and infrastructure development business in Nevada.

Panacos Pharmaceuticals

Market Cap: US$53.0

A development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases.

Inyx

Market Cap: US$53.0

Through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe.

Baudax Bio

Market Cap: US$52.0

A pharmaceutical company, develops and commercializes products for hospital and other acute care related settings.

Arno Therapeutics

Market Cap: US$49.0

A biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

Callitas Health

Market Cap: US$45.0

Provides over the counter consumer health and wellness products in the United States and Canada.

Antigenics

Market Cap: US$45.0

A clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.

Integrative Health Technologies

Market Cap: US$40.0

Provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries.

Response Genetics

Market Cap: US$38.0

A life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally.

Canntab Therapeutics

Market Cap: US$38.0

A phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada.

Claritas Pharmaceuticals

Market Cap: US$37.0

A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.